ILMN

Illumina, Inc.

135.53 USD
-0.01 (-0.01%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Illumina, Inc. stock is down -3.89% since 30 days ago. The next earnings date is Apr 23, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 23 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs. 67% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Feb 20:37 19 Apr, 2024 140.00 PUT 99 0
16 Feb 20:58 17 Jan, 2025 165.00 CALL 22 29
16 Feb 20:59 17 Jan, 2025 120.00 PUT 25 75
20 Feb 14:52 22 Mar, 2024 150.00 CALL 94 143
20 Feb 15:56 21 Jun, 2024 125.00 PUT 39 97
20 Feb 16:45 01 Mar, 2024 145.00 CALL 101 28
20 Feb 19:06 15 Mar, 2024 141.00 CALL 44 0
22 Feb 16:20 19 Apr, 2024 120.00 PUT 117 23
22 Feb 17:52 21 Jun, 2024 120.00 CALL 50 163
22 Feb 17:53 21 Jun, 2024 120.00 CALL 29 163

About Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and Asia-Pacific region.

  • Stephens & Co.
    Wed Feb 14, 11:21
    buy
    confirm
  • RBC Capital
    Fri Feb 9, 11:19
    buy
    confirm
  • Barclays
    Thu Jan 25, 09:47
    sell
    confirm